effect food pharmacokinetics pharmacodynamics fenoldopam class III heart failure Eighteen patients New York Heart Association class III congestive heart failure single mg oral doses fenoldopam food fasting random-order single-blind crossover trial fenoldopam dose thermodilution cardiac output right atrial pressure pulmonary artery pressure pulmonary capillary wedge pressure PCWP balloon-tipped pulmonary artery catheter heart rates blood pressures automated sphygmomanometer fasting bioavailability fenoldopam food mean peak plasma level SEM ng/ml SEM ng/ml mean area concentration-time curve SEM ng.hr/ml SEM ng.hr/ml Fenoldopam administration patients decreases mean arterial pressure systemic vascular resistance PCWP significant increases cardiac index change heart rate maximum changes mean cardiac index systemic vascular resistance PCWP hour oral administration hours administration patients changes cardiac index plasma fenoldopam levels whereas changes PCWP mean arterial pressure observed fenoldopam level 